标题
Nuclear PARP1 expression and its prognostic significance in breast cancer patients
作者
关键词
PARP1, BRCA1, Immunohistochemistry, Prognostic marker, Breast cancer
出版物
TUMOR BIOLOGY
Volume 37, Issue 5, Pages 6143-6153
出版商
Springer Nature
发表日期
2015-11-27
DOI
10.1007/s13277-015-4465-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers
- (2015) Jennifer Stanley et al. BREAST CANCER RESEARCH AND TREATMENT
- DNA damage response markers are differentially expressed in BRCA-mutated breast cancers
- (2015) Mohammed Aleskandarany et al. BREAST CANCER RESEARCH AND TREATMENT
- Olaparib Monotherapy in Patients With Advanced Cancer and a GermlineBRCA1/2Mutation
- (2015) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predicts Poor Survival of Breast Carcinoma Patients
- (2015) See-Hyoung Park et al. Translational Oncology
- Biological and clinical significance of PARP1 protein expression in breast cancer
- (2014) Andrew R. Green et al. BREAST CANCER RESEARCH AND TREATMENT
- A novel crosstalk between BRCA1 and poly (ADP-ribose) polymerase 1 in breast cancer
- (2014) Da Li et al. CELL CYCLE
- Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
- (2014) Jonathan Ledermann et al. LANCET ONCOLOGY
- An update on PARP inhibitors—moving to the adjuvant setting
- (2014) Amir Sonnenblick et al. Nature Reviews Clinical Oncology
- PARP1-Driven Poly-ADP-Ribosylation Regulates BRCA1 Function in Homologous Recombination-Mediated DNA Repair
- (2014) Y. Hu et al. Cancer Discovery
- Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid Tumors
- (2014) Ciara C. O’Sullivan et al. Frontiers in Oncology
- Poly (ADP-ribose) polymerase 1 protein expression in normal and neoplastic prostatic tissue
- (2013) M. Salemi et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- Poly(ADP-ribose) Polymerase 1 Is a Key Regulator of Estrogen Receptor α-dependent Gene Transcription
- (2013) Fengxiao Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial
- (2013) Shahneen K Sandhu et al. LANCET ONCOLOGY
- HER2 Overexpression Renders Human Breast Cancers Sensitive to PARP Inhibition Independently of Any Defect in Homologous Recombination DNA Repair
- (2012) S. Nowsheen et al. CANCER RESEARCH
- Failure of Iniparib to Inhibit Poly(ADP-Ribose) Polymerase In Vitro
- (2012) A. G. Patel et al. CLINICAL CANCER RESEARCH
- Global estimates of cancer prevalence for 27 sites in the adult population in 2008
- (2012) Freddie Bray et al. INTERNATIONAL JOURNAL OF CANCER
- Secondary mutations inBRCA2associated with clinical resistance to a PARP inhibitor
- (2012) Louise J Barber et al. JOURNAL OF PATHOLOGY
- New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
- (2012) Bryan A. Gibson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRCAness Profile of Sporadic Ovarian Cancer Predicts Disease Recurrence
- (2012) Weiya Z. Wysham et al. PLoS One
- Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1 -Mutated Mouse Mammary Tumors
- (2012) Janneke E. Jaspers et al. Cancer Discovery
- Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer
- (2011) F. Rojo et al. ANNALS OF ONCOLOGY
- PARP-1 expression in breast cancer including BRCA1-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapy
- (2011) Pawel Domagala et al. BREAST CANCER RESEARCH AND TREATMENT
- Cytoplasmic Poly(Adenosine Diphosphate–Ribose) Polymerase Expression Is Predictive and Prognostic in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy
- (2011) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- High Nuclear Poly(Adenosine Diphosphate-Ribose) Polymerase Expression Is Predictive forBRCA1- andBRCA2-Deficient Breast Cancer
- (2011) Luka Ozretić et al. JOURNAL OF CLINICAL ONCOLOGY
- Iniparib in Metastatic Triple-Negative Breast Cancer
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer
- (2011) Joyce O'Shaughnessy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Agents and Future Directions for Refractory Breast Cancer
- (2011) Harold J. Burstein SEMINARS IN ONCOLOGY
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy
- (2010) Stuart J Schnitt MODERN PATHOLOGY
- The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets
- (2010) Raga Krishnakumar et al. MOLECULAR CELL
- Declining Death Rates Reflect Progress against Cancer
- (2010) Ahmedin Jemal et al. PLoS One
- Inhibition of poly adenosine diphosphate-ribose polymerase decreases hepatocellular carcinoma growth by modulation of tumor-related gene expression
- (2009) Rosa Quiles-Perez et al. HEPATOLOGY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search